|
Novasep develops, markets and operates innovative technologies to produce synthetic molecules and biomolecules from lab to industrial scale. Our applications cover the pharmaceutical, biopharmaceutical, functional ingredient, food ingredient and bio-industry markets. Pharmaceutical and biopharmaceutical process development, outsourcing and in-sourcingOur unique offering for pharmaceuticals and biopharmaceuticals comprises:
Custom synthesis and purification of APIsOur process development teams select, develop and optimize synthetic routes to provide you with cost-effective solutions in the minimum amount of time (up to 400 chemical steps scaled-up each year). Novasep combines conventional chemistry with special technologies, including:
Batch and continuous chromatography processesNovasep develops batch and continuous chromatography processes, based on its unique pool of proprietary technologies and computer modeling software. Contract synthesis and purificationWe offer contract synthesis and purification in six FDA-inspected facilities for early development, clinical and commercial scale (up to several hundred tons), with full regulatory support. Antibody-drug conjugate development and manufacturingWe now offer complete development and manufacturing services for antibody-drug conjugates (ADC), including mAb production, cytotoxic agent synthesis, conjugation and downstream processing (DSP). Biopharmaceutical manufacturingWe provide a large scope of upstream technologies including microbial (E.coli, L.Lactis and yeast [including pichia pastoris]; insect and mammalian cells; virus (retrovirus, parvovirus, alphavirus, influenza virus, lentivirus, etc.); viral vectors; batch, fed-batch and perfusion modes; and reusable and single-use systems. We also excel in downstream technologies: tangential flow filtration (microfiltration, ultrafiltration and nanofiltration); low, medium and high-pressure bio-chromatography; batch and continuous purification processes; solvent recycling; product conversion/reaction; and reusable and single-use TFF cassettes and systems. Our unique scope of development services includes cell banking (master and working cell banks), analytical transfer and validation, feasibility studies, process modelling, upstream and downstream process development (including formulation and fill and finish) and scale-up. Preclinical to commercial cGMP lot manufactureWe manufacture cGMP lots from preclinical to commercial scale and also provide validation services and comprehensive regulatory support from our three bio-manufacturing facilities. We have a unique organization capable of designing your process, as well as engineering, building, validating and operating a bio-manufacturing plant for your biologics. Supply of chromatography and filtration systemsWith more than 20 years' experience in designing, building and using preparative chromatography systems, Novasep offers:
Biopharmaceutical DSP products and technologiesWe also offer a full range of high performance products and technologies for biopharmaceutical DSP:
Supply of special reagents, building blocks and generic APIsThanks to our unique palette of technologies, we have developed a number of reagents, building blocks and fine chemicals. Moreover, we can provide you with generic APIs produced under cGMP conditions at highly competitive prices, such as paclitaxel, nitroglycerin and heptaminol.
Novasep
Site Eiffel 82 Boulevard de la Moselle - BP 50 54340 Pompey France Tel: +33 383 49 71 30 Fax: +33 383 49 71 49 Email: novasep@novasep.com URL: www.novasep.com |